In a remarkable milestone for the field of ophthalmology, LumiThera, which is one of the world’s top companies offering PBM therapy, has announced new Category III CPT Code for PBM treatments which target retinal disorders. Beginning from January 2025, this important achievement is a step in the right direction toward the improved chances of reimbursement and ill patient’s access to n... https://www.coherentmarketinsights.com/news/lumithera-achieves-approval-of-cpt-code-to-facilitate-retinal-pbm-therapy-revolutionising-non-operative-eye-treatment-1072